Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Early detection of lung cancer to be investigated

Early detection of lung cancer to be investigated

Date time 5 April, 2022
News Type News type Media release
Dr Annalicia Vaughan from the Centenary UTS Centre for Inflammation is the successful recipient of the Kenyon Foundation Inflammation Award for 2022.

The Award, valued at $20,000, will support Dr Vaughan’s study into identifying new microbial-derived biomarkers for the early diagnosis and treatment of lung cancer.

The leading cause of cancer death, lung cancer is responsible for about 9,000 deaths each year in Australia.

In the study, Dr Vaughan will seek to identify biomarkers found in the blood that are associated with microbiota found in the cancerous tissues of the lung.

“Early-stage diagnosis of lung cancer is critical as it is often diagnosed at a late stage – symptoms tend to appear when the disease is already advanced, limiting the range of treatment options available to patients,” said Dr Vaughan.

“The identification of new biomarkers in the blood could be an effective screening tool to detect the presence of lung cancer at an early stage, benefiting patients and at-risk individuals.”

Dr Vaughan says that current research shows that the immune landscape of the lungs plays a vital role in the development of lung cancer as well as in the body’s response to medical therapies such as immunotherapy and chemotherapy.

“We also know that the local microbial lung population is a key regulator of this immune landscape – and that when this microbial population is altered, persistent inflammation and the development of lung cancer can result,” said Dr Vaughan.

“We hope to be able to find relevant biomarkers in the blood that reflect this lung cancer and microbiota association.”

Dr Vaughan said she is thankful for the Kenyon Foundation’s support.

“The funding will help me to undertake research that could ultimately result in a new routine blood screening test for lung cancer in Australia.”

David Kenyon, Trustee of the Kenyon Foundation said, “Lung cancer is one of the most common forms of cancers and can be devastating for those individuals and their families touched by the disease. We’re extremely pleased to be able to support Dr Vaughan’s research into improving lives in this critical health area.”

Kenyon Foundation Inflammation Award 2022 recipient Dr Annalicia Vaughan

Themes

  • Cancer Innovations

    Cancer Innovations
  • Inflammation

    Inflammation

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Early detection of lung cancer to be investigated

Download

Kenyon Foundation Inflammation Award 2022 recipient Dr Annalicia Vaughan

Recent Stories

  • Centenary Institute and Cure the Future join forces to tackle rare diseases

    The Centenary Institute and Cure The Future Foundation have announced a new philanthropic partnership to accelerate research into life-changing treatments for rare genetic diseases and cancers.
    News Type: Media release
    Date 31 Jul 2025
  • New COVID-19 vaccine candidate shows strong protection against multiple variants

    A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney has shown strong potential to protect against both current and emerging coronavirus variants. By targeting features shared by a range of coronaviruses, the vaccine is designed to offer broader and longer-lasting protection as the virus continues to evolve.
    News Type: Media release
    Date 18 Jul 2025
  • New route into cells could make gene therapies safer

    Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and haemophilia.
    News Type: Media release
    Date 15 Jul 2025
  • Centenary researchers awarded TIA Pipeline Accelerator Grants

    Two researchers from the Centenary Institute have secured competitive Pipeline Accelerator Grants from Therapeutic Innovation Australia (TIA), supporting the development of promising medical innovations.
    News Type: Research News
    Date 07 Jul 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram